Event Type
Disclosure
Mandatory
Variant
8-K
. Results of Operations and Financial Condition. On February 26, 2026, Amphastar Pharmaceuticals, Inc. issued a press release announcing its financial results
. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press release, dated February 26, 2026, issued by Amphastar Ph